Galactosamine-6 sulfatase

From WikiMD's WELLNESSPEDIA

Galactosamine-6-sulfatase (GALNS) is an enzyme that plays a crucial role in the metabolism of certain complex carbohydrates in the body. It is involved in the breakdown of keratan sulfate, a type of glycosaminoglycan (GAG) that is found in various tissues, including the cornea, cartilage, and bone.

Function[edit]

GALNS is responsible for removing a specific sulfate group from the keratan sulfate molecule during its degradation process. This is a critical step in the metabolism of this GAG, as it allows for the subsequent breakdown of the molecule into simpler sugars that can be utilized by the body.

Genetics[edit]

The GALNS gene, located on chromosome 16, encodes the GALNS enzyme. Mutations in this gene can lead to a deficiency in GALNS activity, which in turn can result in the accumulation of keratan sulfate in various tissues. This can lead to a range of health problems, depending on the tissues affected.

Clinical significance[edit]

A deficiency in GALNS activity is the underlying cause of Mucopolysaccharidosis IV (MPS IV), also known as Morquio syndrome. This is a rare, inherited metabolic disorder characterized by skeletal abnormalities, vision problems, heart disease, and other symptoms. There are two types of MPS IV, known as MPS IVA and MPS IVB, which are distinguished by whether they are caused by mutations in the GALNS gene (MPS IVA) or another gene (MPS IVB).

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.